Similarly, patients with WR‐DLBCL had a lower probability of an abnormal β2‐microglobulin level (10%) when compared with those with SL‐DLBCL (20%) and with LN‐DLBCL (26%) (p = 0.039). This evidence concerns the gene HLA-G and diffuse large B-cell lymphoma.